Improving the etiological diagnosis of osteoarticular infections with the commercial multiplex real-time polymerase chain reaction SeptiFast®.


Journal

Diagnostic microbiology and infectious disease
ISSN: 1879-0070
Titre abrégé: Diagn Microbiol Infect Dis
Pays: United States
ID NLM: 8305899

Informations de publication

Date de publication:
May 2020
Historique:
received: 25 09 2019
revised: 20 12 2019
accepted: 26 01 2020
pubmed: 27 2 2020
medline: 11 11 2020
entrez: 27 2 2020
Statut: ppublish

Résumé

Detection of etiological agents is pivotal for adequate therapy of osteoarticular bacterial infections. Culture often lacks sensitivity, especially in patients under antibiotic therapy. The present study investigates the potential clinical utility of the commercial multiplex real-time polymerase chain reaction SeptiFast® (SF) in the etiological diagnosis of osteoarticular infections. Results obtained from conventional culture and SF were compared in 86 osteoarticular specimens collected from patients with suspected infection. The number of specimens positive by SF (38/86, 44.18%) was significantly greater (P = 0.001) than that of specimens positive by culture (20/86, 23.25%). The sensitivity of SF was 48.71%, significantly higher than culture sensitivity (25.64%). Specificity was 100% for both tests. The overall diagnostic accuracy for SF was 53.48%, and that of culture was 32.55%. Even with the limitation of the low number of specimens, this study supports the usefulness of SF in the diagnosis of osteoarticular infections.

Identifiants

pubmed: 32098689
pii: S0732-8893(19)30992-7
doi: 10.1016/j.diagmicrobio.2020.115002
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Reagent Kits, Diagnostic 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

115002

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Maria Bruna Pasticci (MB)

Clinic of Infectious Diseases, Department of Medicine, University of Perugia, P.le Gambuli 1, 06132, Perugia, Italy.

Silvia Bozza (S)

Medical Microbiology, Department of Medicine, University of Perugia, P.le Gambuli 1, 06132, Perugia, Italy.

Giuseppe Vittorio De Socio (GV)

Clinic of Infectious Diseases, Perugia General Hospital, P.le Menghini 1, 06129, Perugia, Italy.

Abel Frias-Mazuecos (A)

Medical Microbiology, Department of Medicine, University of Perugia, P.le Gambuli 1, 06132, Perugia, Italy.

Antonella Mencacci (A)

Medical Microbiology, Department of Medicine, University of Perugia, P.le Gambuli 1, 06132, Perugia, Italy. Electronic address: antonella.mencacci@unipg.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH